Table 3.
NETs components detected in patients with different pathologies related to thrombosis.
Biomarker | Patients | Sign Correlated to the Biomarker | References |
---|---|---|---|
DNA | Arterial thrombotic events and diseases | Infarct size | [150,177,178,179,180,181,182,183,184,185,186,189,190] |
Stenosis grade | |||
Severe stroke scores | |||
Hypercoagulability markers | |||
High glucose levels | |||
Thrombus age | |||
Venous thromboembolic events | Thromboembolism extent | [187,188] | |
C-reactive protein | |||
Hypertension | Homocysteinemia | [193] | |
Other diseases | ITP: Platelet CD62 *† | [191] | |
Behçet’s disease: Vascular involvement | [192] | ||
Cushing disease: ETP ratio | [194] | ||
Nucleosomes | Arterial thrombotic events and diseases | Infarct size | [178,185,190] |
Stenosis grade | |||
Severe stroke scores | |||
High glucose levels | |||
Venous thromboembolic events | Thromboembolism extent | [187] | |
Other diseases | Cushing disease: ETP ratio | [194] | |
citH3/H4 | Arterial thrombotic events and diseases | Infarct size | [180,181,184,189,190] |
Stenosis grade | |||
Severe stroke scores † | |||
High glucose levels † | |||
Thrombus age, stabilization and growth | |||
Venous thromboembolic events | Lactate levels | [195] | |
Other diseases | ITP: Platelet CD62 *† | [191] | |
MPO | Arterial thrombotic events and diseases | Stenosis grade ‡ | [185] |
Venous thromboembolic events | C-reactive protein | [195] | |
D-dimer | |||
Hypertension | Homocysteinemia ‡ | [193] | |
Other diseases | Behçet’s disease: Vascular involvement ‡ | [192] | |
Cushing disease: ETP ratio | [194] | ||
NE | Arterial thrombotic events and diseases | Thrombus stabilization and growth | [184] |
NETs: Neutrophil extracellular traps. DNA: Desoxyribonucleic acid. citH3/H4: citrullinated histone H3/H4. MPO: Myeloperoxidase. NE: neutrophil elastase. ITP: Primary immune thrombocytopenia. CD: cluster of differentiation. ETP: Endogenous thrombin potential. * Negative correlation. † DNA-citH3 complexes. ‡ DNA-MPO complexes.